At a glance
ClinicalIndex Comparison RecordN/ACompleted· 250 enrolled
Drug / intervention
AcrySof IQ PanOptix Multifocal IOL +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Investigation of AcrySof® IQ PanOptix™ IOL Model TFNT00
In Brief
A clinical study evaluating AcrySof IQ PanOptix Multifocal IOL and AcrySof Monofocal IOL for Cataract. Completed, enrolled 250 participants across 12 sites.
Detailed Summary
The purpose of this clinical study is to compare the visual outcomes of the AcrySof IQ PanOptix Multifocal Intraocular Lens (IOL) Model TFNT00 against that of a monofocal lens, the AcrySof Monofocal IOL Model SN60AT, in order to demonstrate comparable distance vision and superior near and intermediate vision.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedSep 2017
Enrollment StartNov 2017
Primary CompletionSep 2018
TodayJul 2026
First PostedSep 12, 2017
Enrollment StartNov 1, 2017
Primary CompletionSep 27, 2018
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 8.8 years ago
Interventions
AcrySof IQ PanOptix Multifocal IOLdevice
AcrySof IQ PanOptix Multifocal IOL Model TFNT00 for near, intermediate, and distance vision
AcrySof Monofocal IOLdevice
AcrySof Monofocal IOL Model SN60AT for single vision